U.S. Transportation Stock News

Etsy reported its second quarter 2025 earnings, revealing sales of US$672.66 million and net income of US$28.84 million, alongside the completion of a buyback program that repurchased 10,067,260 shares for US$523.36 million. The company has also shifted its marketing strategy toward AI-driven search and digital personalization, aiming to revitalize platform engagement and address previous declines in buyer numbers. We’ll now explore how Etsy’s focus on AI-powered search and buyer engagement...

Banc of California, Inc. recently declared a quarterly cash dividend of US$0.10 per common share and a US$0.4845 dividend per depositary share for its 7.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series F, with record dates in August and September 2025. This dividend affirmation follows the release of the company's second quarter 2025 results, which highlighted increased loans held for sale and expanded product offerings, as well as its addition to multiple Russell...

Last month, Johnson Controls International reported third quarter 2025 earnings, posting higher revenues of US$6.05 billion but a significant year-over-year drop in net income to US$701 million, alongside confirming ongoing operational realignment into three geographic segments. An interesting insight is that the company cited one-off items impacting profits, revised its annual guidance to reaffirm mid-single digit organic sales growth, and completed a substantial share buyback tranche...

On August 5, 2025, Newegg Commerce, Inc. announced the launch of the Newegg Gamer Community, a new digital platform on Newegg.com and the Newegg app designed for gamers, PC builders, and technology enthusiasts to connect, share, and engage with each other and Newegg staff. This initiative highlights Newegg’s ongoing push to foster deeper connections with its core audience and create a hub for PC-centric culture and collaboration. We’ll explore how the focus on community engagement through...

CVR Partners, LP recently announced a strong second quarter with higher sales and net income, an increased cash distribution of $3.89 per common unit, and the filing of a $49.25 million shelf registration related to an ESOP offering. This combination of financial milestones and corporate actions highlights the company's focus on both rewarding unitholders and supporting future equity initiatives. We’ll explore how the significant dividend hike may shape CVR Partners' investment narrative...

IDEAYA Biosciences recently reported second quarter 2025 earnings, revealing a net loss of US$77.49 million, up from US$52.77 million a year earlier, and announced a US$50 million shelf registration to offer 2,000,000 shares of common stock. These back-to-back updates reflect both a widening financial loss and plans to raise capital, signaling shifts in the company’s operational and funding landscape. We’ll now explore how the combination of increased net losses and the new capital raise...

Mueller Industries recently announced that its Board of Directors declared a regular quarterly cash dividend of US$0.25 per share, payable on September 19, 2025, to shareholders of record as of September 5, 2025. While the company reported strong profits, a significant portion stemmed from an unusual US$60 million one-time gain, raising questions about the sustainability of its core earnings. We'll explore how reliance on significant one-time gains affects Mueller Industries' investment...

In the past week, Jones Lang LaSalle reported second quarter 2025 earnings with sales of US$6,250.1 million and net income of US$112.3 million, while also announcing an increase in planned share repurchases through the end of the year. Management reaffirmed a focus on returning capital to shareholders and exploring selective acquisitions, highlighting a disciplined capital allocation approach amid ongoing operational growth. We'll explore how management's increased commitment to share...

Regeneron Pharmaceuticals reported strong second quarter 2025 results, with revenue reaching US$3.68 billion and key products like EYLEA HD and Dupixent driving growth, while also announcing a US$0.88 dividend and giving a business update on share repurchases and FDA approvals. The recent FDA approval of Dupixent for bullous pemphigoid sets the stage for expanding the reach of one of Regeneron's most important therapies. We'll explore how strong second quarter earnings and expanded Dupixent...

Kennedy-Wilson Holdings recently reported second quarter 2025 results, highlighting US$93.3 million in sales, US$135.7 million in revenue, and a return to net income of US$4.5 million versus a net loss a year ago, while affirming a US$0.12 per share dividend for the third quarter of 2025. The company made considerable progress reducing debt, focusing capital deployment on rental housing, now 65% of assets under management, and generating substantial proceeds from non-core asset sales to fund...

Gogo Inc. recently reported strong results for the second quarter of 2025, with revenue reaching US$226.04 million and net income of US$12.81 million, both more than doubling compared to the same period last year. An important development is Gogo's decision to raise its full-year revenue and earnings guidance, which follows continued operational outperformance, integration progress, and planned 5G product launches. We'll explore how Gogo's upgraded financial guidance and integration...

Ardelyx recently announced a series of significant developments, including raising its 2025 IBSRELA sales guidance to US$250–260 million, reporting strong second-quarter revenue of US$97.66 million, and making key leadership changes with Edward Conner, M.D. appointed as Chief Medical Officer and John Bishop, Ph.D. named Chief Technical Operations Officer. These updates point to growing confidence in the commercial outlook for IBSRELA, while also signaling an organizational shift as Ardelyx...

Pacira BioSciences recently reported its second-quarter 2025 results, highlighting revenue of US$181.1 million and a new collaboration with Johnson & Johnson MedTech aimed at expanding ZILRETTA's market reach. This partnership, along with improved non-GAAP gross margin guidance and ongoing progress in key clinical programs, signals an effort to accelerate commercial growth despite mixed quarterly financials. We'll explore how the Johnson & Johnson MedTech collaboration could shape Pacira's...

MercadoLibre reported its second quarter 2025 earnings, posting strong revenue growth to US$6.79 billion from US$5.07 billion a year earlier, while net income edged slightly lower at US$523 million compared to US$531 million. An especially interesting insight is the company's robust commerce and fintech expansion was accompanied by higher marketing spend and adjustments to its free shipping policy in Brazil, which affected short-term profitability. We'll explore how this mix of accelerated...

Axos Financial, Inc. recently announced its fourth quarter 2025 results, reporting net interest income of US$280.16 million and net income of US$110.68 million, both higher than the prior year. Both basic and diluted earnings per share from continuing operations increased year-over-year, highlighting operational strength during the quarter. We'll explore how Axos Financial's stronger net income and earnings per share influence the company's growth-focused investment narrative. The latest...

Maricopa County and KinderCare Learning Companies recently opened the Maricopa County Kids Club, an early learning center in downtown Phoenix offering extended-hours care for county employees' children from infancy through age five. This collaboration highlights an increasing trend where employers invest in on-site child care and flexible benefits to attract and retain top talent. Next, we'll explore how KinderCare's focus on flexible, employer-sponsored child care solutions shapes its...

Between April and June 2025, Texas Instruments repurchased 1,847,766 shares for US$289.59 million, completing its buyback program from 2018 with a total of 49,938,873 shares repurchased for US$7.70 billion. This significant buyback coincided with Texas Instruments being recognized by a major investment fund for effectively managing tariff risks through flexible manufacturing across global regions. We'll now examine how Texas Instruments' agile supply chain management could influence its...

Rithm Capital Corp. recently reported second quarter 2025 earnings, posting net income of US$311.72 million and diluted earnings per share of US$0.53, and also settled a previously disclosed board-related lawsuit for US$160,000 in attorneys’ fees without admitting any wrongdoing. Additionally, the company filed a broad shelf registration for multiple security types, while recent coverage highlighted the preferred stock’s strong dividend security and asset coverage, making it an area of...

Earlier this month, Ally Financial announced the issuance of two fixed-rate senior unsecured notes: a 5.750% bond due August 2035 and a 4.700% bond due August 2028, both callable and issued at par with modest discounts per security. This move reflects Ally’s ongoing efforts to secure long-term funding and demonstrates investor confidence in the company's creditworthiness following strong second quarter results. We will explore how Ally’s recent fixed-income offering and impressive quarterly...

MetLife, Inc. recently reported its second-quarter 2025 results, posting revenue of US$17.34 billion and net income of US$729 million, both down compared to the same period last year and missing analyst estimates. A key insight was that growth in Latin America and EMEA partially offset weaker performance in Asia and core business segments, but could not fully counteract lower underwriting and investment returns. Let's examine how the earnings shortfall and business mix challenges may...

BridgeBio Pharma reported past second quarter results showing a surge in revenue to US$110.57 million, mainly driven by growth in its recently launched drug Attruby, while its net loss widened to US$181.9 million compared to the previous year. This strong performance included substantial increases in prescription and patient numbers for Attruby, alongside positive clinical results indicating reduced risk of adverse cardiac events. We'll explore how Attruby's rapid market uptake and promising...

NewMarket Corporation has reported its second-quarter 2025 earnings with net income holding steady at US$111.24 million and announced a US$2.75 quarterly dividend payable on October 1, 2025, along with the completion of a share repurchase tranche totaling 133,658 shares for US$71.79 million. These actions emphasize the company's focus on consistent capital returns and earnings stability, despite a slight year-over-year decrease in sales revenue. We'll explore how NewMarket's recent dividend...

In the second quarter of 2025, Philip Morris International’s e-vapor brand VEEV reported shipment volumes that more than doubled year over year, with the company launching VEEV inPRIME in the Czech Republic and expanding into markets such as Indonesia, Canada, and Colombia. This rapid growth in VEEV highlights Philip Morris International’s ongoing transition toward a broader smoke-free product strategy, aiming to capture new consumer segments and strengthen its premium positioning...

Cboe Global Markets recently reported second quarter 2025 results, posting record revenue of US$1.17 billion and net income of US$235.1 million, both up markedly from the prior year; the company also announced robust July trading volume figures and reached over 1,000 U.S. ETF listings. In addition to strong financials, Cboe raised its full-year 2025 organic net revenue growth guidance to the high single digits and closed its Japan equities business to focus on higher-return opportunities and...